CAIRO - 7 March 2026: Dr. Ali Awf, head of the pharmaceuticals division at the Federation of Chambers of Commerce, stated that the Egyptian pharmaceutical market has been stable for the past year and a half, with no price fluctuations and very few drug shortages.
This stability is attributed to the steady exchange rate of the US dollar against the Egyptian pound, which has even declined during this period.
However, the outbreak of the US-Iranian conflict has begun to affect the dollar's value. He added, "Raw materials and medications in pharmacies are sufficient for 10 months."
In statements to Egypt Toady, Dr. Awf emphasized that Egypt's drug reserves are completely secure and that the Egyptian Drug Authority is closely monitoring the markets. He asserted that the situation is entirely under control. He continued, "But no one knows when the war will end, not even the US, which initiated it."
Dr. Awf confirmed that the closure of the Strait of Hormuz will drive up drug prices due to a 300% increase in shipping costs and a 50% increase in insurance costs, as announced by insurance companies. He concluded, "This will result in a 30% increase in the cost of manufacturing Egyptian pharmaceuticals."
Awf pointed out that if the US-Iranian war continues for more than three months, we will see an increase in drug prices. He explained that new contracts for raw materials and active pharmaceutical ingredients, which will be finalized three months from now, will bear the costs of the war, including increased shipping and insurance expenses.
The head of the pharmaceutical division added, "Since the beginning of July, I have to place my orders to maintain stock levels, and I will be paying an additional 30% out of my own pocket, which will increase the cost."
Comments
Leave a Comment